Omega Fund IV G.P. Manager, Ltd.
SEC CIK 1624456 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | 10% | 4.67M | — | $2.78M | 5 | 2021-11-04 | 2022-03-15 |
Most active insiders at REPL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Sushil | CEO, Dir | — | $811.2K |
| 2 | Hill Emily Luisa | CFO | — | $320.3K |
| 3 | Xynos Konstantinos | Chief Medical Off | — | $285.7K |
| 4 | Sarchi Christopher | Chief Commercial Off | — | $254.2K |
| 5 | Schwendenman Andrew | CAO | — | $139.1K |
| 6 | Astley-Sparke Philip | Dir | — | $89.7K |
| 7 | Dhingra Kapil | Dir | — | $33.0K |
Omega Fund IV G.P. Manager, Ltd. made no open-market trades at REPL in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-03-16 | 2022-03-14 | REPL | Replimune Group, Inc. | Omega Fund IV G.P. Manager, Ltd. | 10% | M - OptEx | $9.78 | +16.5K | 4.78M | +0.3% | +$161.4K |
| DI | 2022-03-16 | 2022-03-14 | REPL | Replimune Group, Inc. | Omega Fund IV G.P. Manager, Ltd. | 10% | S - Sale+OE | $15.42 | -16.5K | 4.76M | -0.3% | -$254.4K |
| DM | 2022-03-16 | 2022-03-15+ | REPL | Replimune Group, Inc. | Omega Fund IV G.P. Manager, Ltd. | 10% | S - Sale+OE | $15.58 | -90.0K | 4.67M | -2% | -$1.40M |
| M | 2021-11-18 | 2021-11-16+ | REPL | Replimune Group, Inc. | Omega Fund IV G.P. Manager, Ltd. | 10% | S - Sale | $33.50 | -2,594 | 4.81M | -0.1% | -$86.9K |
| M | 2021-11-08 | 2021-11-04+ | REPL | Replimune Group, Inc. | Omega Fund IV G.P. Manager, Ltd. | 10% | S - Sale | $33.57 | -31.0K | 4.87M | -0.6% | -$1.04M |
Purchase Sale Sale after option exercise All abbreviations